Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study by Ree, Anne Hansen, Prof, Dueland, Svein, MD, Folkvord, Sigurd, MD, Hole, Knut H, MD, Seierstad, Therese, PhD, Johansen, Marianne, RN, Abrahamsen, Torveig W, BSc, Flatmark, Kjersti, MD

Get full text